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Proteome-wide analysis of cysteine oxidation
reveals metabolic sensitivity to redox stress
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Reactive oxygen species (ROS) are increasingly recognised as important signalling molecules
through oxidation of protein cysteine residues. Comprehensive identiﬁcation of redox-
regulated proteins and pathways is crucial to understand ROS-mediated events. Here, we
present stable isotope cysteine labelling with iodoacetamide (SICyLIA), a mass spectrometry-
based workﬂow to assess proteome-scale cysteine oxidation. SICyLIA does not require
enrichment steps and achieves unbiased proteome-wide sensitivity. Applying SICyLIA to
diverse cellular models and primary tissues provides detailed insights into thiol oxidation
proteomes. Our results demonstrate that acute and chronic oxidative stress causes oxidation
of distinct metabolic proteins, indicating that cysteine oxidation plays a key role in the
metabolic adaptation to redox stress. Analysis of mouse kidneys identiﬁes oxidation of
proteins circulating in bioﬂuids, through which cellular redox stress can affect whole-body
physiology. Obtaining accurate peptide oxidation proﬁles from complex organs using SICyLIA
holds promise for future analysis of patient-derived samples to study human pathologies.
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Cancer cells are known to produce more reactive oxygenspecies (ROS) compared to non-transformed cells1,2. Highlevels of ROS can cause oxidation of DNA, lipids, and
proteins3. This can have profound consequences for cellular
function, as oxidation of DNA can lead to cancer via the gen-
eration of mutations and DNA strand breaks. End-products of
lipid peroxidation can also act as mutagens by forming DNA
adducts, whereas direct oxidation of membrane lipids can com-
promise membrane integrity4. In contrast to damaging oxidative
stress, ROS have also been shown to be instrumental signalling
intermediates through modiﬁcation of protein cysteine residues5.
Whereas irreversible oxidation of proteins may lead to their
dysfunctionality, reversible oxidation of cysteine residues allows
for modulation of activity, engagement in redox regulation, and
signalling cascades2,6,7.
To understand the full scope of ROS (as well as reactive
nitrogen species), comprehensive identiﬁcation of redox-
regulated proteins and cellular pathways is essential. In recent
years, advancements in mass spectrometry (MS) technology have
brought forth several strategies to assess cysteine thiol oxidation
proﬁles (recently reviewed in8). However, identifying modiﬁed
cysteine residues on a whole-proteome scale remains a technical
challenge, as cysteine content in proteins is low (approximately
2.3% of the proteome9), with an even smaller proportion that is
reversibly oxidised at any given time. Another complicating factor
is the broad variety of oxidative modiﬁcations that cysteine thiols
can undergo, such as sulfenylation, nitrosylation, and glutathio-
nylation, which further fractionates the cysteine proteome.
Therefore, highly sensitive tools are required to detect reversibly
oxidised thiols in proteomes. This constraint can be circumvented
by the use of multistep protocols to enrich for cysteine-containing
peptides or subpopulations of oxidised cysteine residues, such as
isotope-coded afﬁnity tags (ICAT)10, OxICAT11, iodoacetyl iso-
baric tandem mass tags (iodoTMT)12 or OxiTMT13, isotopic
tandem orthogonal proteolysis–activity-based protein proﬁling
(isoTOP-ABPP)14, and other approaches using click-chemistry15.
A disadvantage of such enrichment approaches is that they
require extensive manipulation of samples, which increases the
possibility of sample loss and contamination during preparation.
Most importantly, speciﬁc or insufﬁcient enrichment can intro-
duce bias. To mitigate these issues, we developed a simple,
unbiased, and robust quantitative proteomic approach (SICyLIA)
to sensitively detect and accurately measure proteome-wide
cysteine oxidation dynamics under conditions of acute and
chronic oxidative stress. Light or heavy stable isotope-labelled
iodoacetamide (IAM) is used to differentially modify free reduced
cysteine thiols between two samples, and the ratio between heavy
and light IAM-labelled cysteine containing peptides is used to
compare the levels of reduced cysteine residues between samples.
The relative change of IAM modiﬁcation on a cysteine residue
within a given peptide is then used as readout for cysteine thiol
oxidation. This enables the identiﬁcation of redox-targeted
cysteine residues without discriminating for a speciﬁc oxidative
modiﬁcation. As reduced protein thiols are the more abundant
cysteine species in cells, we achieve proteome-wide sensitivity
without the need for enrichment steps. Importantly, this high
sensitivity allows for the detection of smaller, but biologically
relevant, changes in oxidation states. After labelling, proteomes
are analysed by combining off-line high pH reversed phase
chromatography for peptide fractionation, which has been shown
to have exceptional peptide separation efﬁciency16–18, with on-
line reverse phase nano-ﬂow ultra-high pressure liquid chroma-
tography (UHPLC), followed by an ultra-high-ﬁeld Orbitrap
mass analyser19. Data are then analysed with the MaxQuant
computational platform, which allows highly accurate peptide
and protein quantiﬁcation20. As such, the SICyLIA workﬂow
informs on cysteine thiols at whole proteome level without the
need to use enrichment steps, includes all possible cysteine thiol
oxidative modiﬁcations, and is broadly accessible due to its
simplicity.
In this study, SICyLIA was used to proﬁle protein oxidation in
diverse cellular models and primary tissues. Previously char-
acterised fumarate hydratase (FH)-deﬁcient (Fh1−/−) mouse
immortalised primary kidney epithelial cells and kidney tissues
were compared to wild-type isogenic controls (Fh1ﬂ/ﬂ) as a model
of chronic oxidative stress21–24. FH is a tricarboxylic acid cycle
enzyme that converts fumarate to malate, and inactivating
mutations in FH are associated with the highly malignant her-
editary leiomyomatosis and renal cell cancer25. We have pre-
viously elucidated the mechanism by which fumarate reacts with
reduced glutathione (GSH) to form the covalent adduct succi-
nicGSH in FH-deﬁcient cells, which leads to GSH and NADPH
depletion and results in chronic oxidative stress24. As a model of
acute oxidative stress, Fh1ﬂ/ﬂ cells were treated with physiologi-
cally recoverable concentrations of hydrogen peroxide (H2O2).
Our data suggest that both acute and chronic oxidative stress
induce speciﬁc metabolic adaptations through oxidation of dis-
tinct metabolic proteins. Furthermore, analysis of kidney pro-
teomes suggests that chronic intracellular oxidative stress may
have profound effects on tissue remodelling and whole-body
physiology through oxidation of proteins in circulating bioﬂuids.
Results
Proteomic quantiﬁcation of global cysteine oxidation. Figure 1
illustrates the SICyLIA workﬂow to directly compare cysteine
oxidation in two diverse samples on a whole proteome scale.
Control and oxidatively stressed cells or tissue samples were
extracted separately in the presence of either light (12C2H4INO)
or stable isotope-labelled heavy (13C2D2H2INO) IAM to alkylate
reduced cysteine thiols (SH), coupling a carbamidomethyl (CAM)
group to the cysteine residue. After labelling, equal amounts of
protein extracts were mixed using a label-swap replication strat-
egy and treated with dithiothreitol (DTT) to reduce reversibly
oxidised thiols, which were subsequently blocked with n-
ethylmaleimide (NEM). Proteomes were then digested and pep-
tides fractionated using off-line high pH reversed phase chro-
matography prior to UHPLC-MS/MS analysis on a Q-Exactive
HF. Cysteine oxidation ratios are calculated using the MaxQuant
computational platform20 based on the abundance of light and
heavy CAM-modiﬁed peptide pairs for each cysteine-containing
unique peptide. As IAM reacts with reduced cysteine thiols, a
decrease in CAM-modiﬁcation for a given peptide indicates
increased cysteine oxidation. Whereas changes in the levels of
reduced cysteine between samples undergoing a short-term
treatment can be compared immediately (Fig. 1a), different cell
lines or tissues derived from different mice have distinct pro-
teomes and require normalisation for protein levels. For relative
protein quantiﬁcation, stable isotope dimethyl labelling26 was
used in conjunction with IAM labelling (Fig. 1b). This method
follows a comparable workﬂow as described above, streamlining
these parallel procedures. As shown in Fig. 1b, a fraction of the
lysates used to prepare IAM-labelled samples are digested and
dimethylated with either light (H12CHO/NaBH3CN) or heavy
(D13CDO/NaBD3CN) formaldehyde/sodium cyanoborohydride,
mixed in equal ratios using a label-swap replication strategy for
independent replicates, and subjected to high pH reversed phase
chromatography fractionation before UHPLC-MS/MS analysis.
Protein abundance was then determined using MaxQuant.
Finally, peptide oxidation ratios are normalised for protein
abundance, providing the normalised oxidation ratio for each
cysteine-containing peptide in the analysed proteome.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04003-3
2 NATURE COMMUNICATIONS |  (2018) 9:1581 | DOI: 10.1038/s41467-018-04003-3 | www.nature.com/naturecommunications
The SICyLIA workﬂow was applied to diverse biological
models of acute (H2O2 treatment) and chronic (Fh1 deﬁciency)
oxidative stress to assess its performance (Fig. 2). SICyLIA
enabled quantiﬁcation of 18,022 unique cysteine-containing
peptides in mouse cells and 13,112 in kidney tissues (Fig. 2a).
To achieve accurate cysteine oxidation ratios, stringent quality
control (QC) criteria were applied. First, only peptide oxidation
ratios quantiﬁed in at least three replicates were considered for
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Fig. 1 Schematic overview of the Stable Isotope Cysteine Labelling with IodoAcetamide (SICyLIA) methodology. a Samples are extracted in presence of
either light (12C2H4INO) or heavy (13C2D2H2INO) iodoacetamide (IAM) to alkylate free cysteine thiols, introducing a carbamidomethyl (CAM) group.
Equal amounts of modiﬁed protein extracts are mixed, reversibly oxidised thiols are reduced with DTT and subsequently alkylated with NEM. Protein
extracts are digested and peptides are fractionated prior to UHPLC-MS/MS analysis. b In parallel, labelled proteome extracts are trypsin digested and
dimethylated using light (H12CHO/NaBH3CN) or heavy (D13CDO/NaBD3CN) formaldehyde/sodium cyanoborohydride, peptides are fractioned, and
analysed using UHPLC-MS/MS similarly to IAM-modiﬁed peptides
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the analysis. Additionally, the coefﬁcient of variation (CV%)
between replicates was used to ﬁlter out extreme outlier ratios
(see Methods). After QC, the median oxidation ratio between
replicates was used for further analysis. Oxidation ratios for up to
9479 peptides in the cells and 4415 in tissues were included for
further analysis, which corresponds to 3563 and 2168 proteins,
respectively. Overall, variability across our data sets was low
(Fig. 2b) and replicates showed high reproducibility, with median
CV% of 15.1 (H2O2 model), 17.7 (Fh1 cell model), and 16.0 (Fh1
tissue model) (Fig. 2c). To deﬁne which cysteine-containing
peptides were signiﬁcantly oxidised or reduced, the Signiﬁcance B
algorithm in the Perseus software platform was used27. This
algorithm was speciﬁcally developed for the analysis of mass
spectrometry-based protein/peptide quantiﬁcation using log
protein/peptide ratios20 (see Methods). For an extended sub-
stantiation of QC strategy and discussion regarding suitability of
different statistical analysis strategies for the evaluation of peptide
oxidation ratios generated with SICyLIA, see Supplementary
Note 1. In the analysed models, we identiﬁed 333 (H2O2 model),
252 (Fh1 cell model), and 150 (Fh1 tissue model) signiﬁcantly
oxidised or reduced peptides, corresponding to 3.5, 2.9, and 3.4%
of the respective data sets (Fig. 2a).
ROS induce metabolic adaptation through protein oxidation.
To provide a relevant study of acute cellular oxidative stress using
hydrogen peroxide administration, a treatment regimen that
induces recoverable acute oxidative stress in cells was determined.
Hydrogen peroxide levels were quantiﬁed by measuring the oxi-
dation of phenylboronate to phenol by mass spectrometry (see
Methods and Supplementary Fig. 1a). This assay demonstrated
sensitivity (LOD= 1 µM) and linearity in the concentration range
used for this study (Supplementary Fig. 1b) and appropriate
controls show stability of the detection probe over time (Sup-
plementary Fig. 1c). Quantiﬁcation of hydrogen peroxide stability
in culture media showed that it decomposes slowly in the absence
of cells, but is rapidly taken up or metabolised by cells, with a
half-life between 15 and 30 min (Fig. 3a). Based on these results,
Fh1ﬂ/ﬂ control cells were treated with hydrogen peroxide for
15 min, after which residual hydrogen peroxide was removed by
replenishing the medium (quantiﬁcation in Fig. 3a show that an
average 64% of the hydrogen peroxide dose administered still
remained in the medium at this point). This approach ensures
that at this time point, cells are still exposed to, and detoxifying,
hydrogen peroxide. Cells were considerably affected by this
treatment, but retain short term proliferative capacity (Fig. 3b) as
well as some long term colony formation capability (Fig. 3c and
Supplementary Fig. 1d). To validate the redox stress induced by
this treatment, intracellular metabolites were analysed for mar-
kers of oxidative stress. As seen in Fig. 3d, treatment with 500 µM
hydrogen peroxide for 15 min led to signiﬁcantly increased ratios
for NAD(P)+/NAD(P)H and oxidised over reduced glutathione
(GSSG/GSH). Together, these results indicate that this treatment
regimen caused acute and severe oxidative stress, yet cells were
able to restore homoeostasis over time.
Using SICyLIA, we set out to assess protein cysteine oxidation
in Fh1ﬂ/ﬂ cells treated with hydrogen peroxide. To determine
whether this 15-min treatment caused changes in global protein
levels, protein abundance was compared between samples using
label-free quantiﬁcation (LFQ). This test was used to decide
whether normalisation for protein levels (Fig. 1b) was required to
compare cysteine oxidation levels between samples. Protein
abundance in untreated and hydrogen peroxide-treated cells
showed strong correlation (Supplementary Fig. 2a–b). Only two
of the 2143 proteins quantiﬁed (0.09%) were of signiﬁcantly
different abundance between conditions (t-test analysis, FDR
0.05). Therefore, we concluded that protein normalisation was
not required for this short treatment. Using the SICyLIA
workﬂow (Fig. 1a), protein cysteine oxidation was assessed to a
depth of 18,022 cysteine-containing peptides (Fig. 2a and
Supplementary Data 1). Of those, 9479 were robustly quantiﬁed
according to our QC criteria. These peptides belonged to 3563
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Fig. 2 Performance indicators and reproducibility of the SICyLIA workﬂow. a Number of peptides and proteins identiﬁed using SICyLIA in the three
experimental models, broken down into indicated classes. b Histogram distribution and c boxplots of the coefﬁcient of variation (CV%) of peptide oxidation
ratios between four replicates as identiﬁed using SICyLIA for the three experimental models. Boxplots display 25th and 75th percentile (bounds of box),
median (centre line), and largest and smallest value (whiskers) of the distribution. a–c Based on four independent experiments, single measurement (H2O2
model, Fh1 cell model) or the comparison of one mouse per genotype, using four replicate tissue slices per mouse (Fh1 tissue model)
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protein groups. Figure 4a displays the log2 median peptide
oxidation ratio upon hydrogen peroxide treatment vs. the
intensity of the peptides, with positive values (right side)
representing more oxidised peptides and negative values (left
side) representing more reduced peptides after treatment. As
shown in Supplementary Figure 2c, the standard deviation of the
replicates for the majority of peptides was low, thus justifying the
use of the median oxidation ratio only for Signiﬁcance B
evaluation (see Supplementary Note 1) to determine signiﬁcantly
modiﬁed peptides. A subset of 333 peptides (3.5%) were
signiﬁcantly more oxidised or reduced upon treatment (Fig. 4a).
To investigate the functional consequences of this global
oxidation proﬁle, we analysed whether these cysteine residues
resided on functional domains (Supplementary Data 1). Uni-
Prot28 Feature Keys indicate whether cysteine residues have been
shown to engage in speciﬁc functions, such as catalytic activity or
metal ion binding. Figure 4b displays the Feature Keys for all
cysteine residues in our dataset that were annotated in UniProt.
Cysteine residues signiﬁcantly modiﬁed after hydrogen peroxide
treatment were found to reside predominantly in protein active
sites, whereas those involved in metal ion binding were generally
less reactive to oxidation upon hydrogen peroxide treatment.
Cysteine residues involved in disulphide bond formation were
signiﬁcantly modiﬁed in speciﬁc proteins, most notably the
peroxiredoxin family members (Prdx1-6). These are well-
characterised antioxidant enzymes that control cellular peroxide
levels29. The two-cysteine peroxiredoxin catalytic mechanism
revolves around oxidation of the active site (peroxidatic) cysteine
that is subsequently attacked by the resolving cysteine on the
other subunit, forming a disulphide bond. In turn, these are
reduced by dedicated oxidoreductase enzymes, returning the
peroxiredoxins to their basal reduced state. These results indicate
that the cells are actively detoxifying ROS. This was further
conﬁrmed by gene ontology (GO) category analysis30,31 of
signiﬁcantly modiﬁed peptides, which showed enrichment of
proteins involved in stress and ROS response in GO biological
process (GOBP; Fig. 4c) and in antioxidant, peroxiredoxin, and
peroxidase activity in GO molecular function (GOMF; Fig. 4d).
Additionally, a strong enrichment was found for the mitochon-
drial cellular compartment (GOCC; Fig. 4e).
Oxidised proteins identiﬁed using SICyLIA (Fig. 4a) included
several proteins that are known to be readily oxidised. These
include PTEN, PARK7, and GAPDH. Oxidation of the essential
Cys124 residue of the lipid phosphatase tumour suppressor PTEN
has been shown to lead to its inactivation32. PARK7 (also known
as protein deglycase DJ-1) has been suggested to be a negative
regulator of PTEN33 as well as a scavenger of ROS34 and stabiliser
of the transcription factor NRF2, a master regulator of the cellular
response to redox stress35. Oxidation of the Cys106 residue of
PARK7 is required for its function36. For GAPDH, the Cys152 in
its active site has been shown to be exceptionally reactive to
hydrogen peroxide through a proton relay mechanism, similar to
the system found in dedicated thiol peroxidases37. In line with the
literature, our proteomics approach identiﬁed the oxidation of
these particular cysteine residues (Supplementary Data 1).
Interestingly, enrichment analysis of signiﬁcantly modiﬁed
peptides based on GOBP showed strong enrichment for
metabolic proteins (Fig. 4c). A bioinformatics comparison of
cysteine content showed that metabolic proteins do not differ in
cysteine content compared to other proteins (12 cysteine residues
per protein on average across the whole mouse proteome, as well
as in metabolic proteins deﬁned by GOBP). The enrichment in
the oxidation of cysteine residues of metabolic proteins suggests
that this is a selective response to oxidative stress. To validate the
functional consequences of oxidative modiﬁcation, we focused on
the metabolic enzyme GAPDH that had one of the largest
oxidation ratios in our dataset (Fig. 4a). GAPDH catalyses the
NAD+-dependent conversion of glyceraldehyde 3-phosphate
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(G3P) to 1,3-bisphosphoglycerate in glycolysis. To investigate
cellular metabolic alterations upon hydrogen peroxide treatment,
intracellular levels of metabolites were analysed by liquid
chromatography-mass spectrometry (LC-MS). Hydrogen perox-
ide treatment in Fh1ﬂ/ﬂ cells caused rapid accumulation of upper
glycolysis intermediates up to G3P, with a concomitant decrease
in downstream glycolytic metabolites, indicating a block in
GAPDH activity (Fig. 5a). To investigate how GAPDH inhibition
affects the metabolic fate of glucose after oxidative stress, cells
were incubated with uniformly labelled 13C6-glucose for 15 min
in the presence or absence of hydrogen peroxide and metabolites
with different amount of glucose-derived 13C isotopes (isotopo-
logues) were analysed. The rapid accumulation of multiple
isotopologues in metabolites of upper glycolysis and the pentose
phosphate pathway (PPP) revealed that GAPDH inhibition by
hydrogen peroxide induces rapid diversion of glycolytic ﬂux into
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the PPP, and further, multiple rounds of cycling of carbons
through the oxidative arm to amplify NADPH production and
combat ROS (Fig. 5b). Furthermore, the accumulation of the
GAPDH substrate G3P (Fig. 6a) and the depletion of the
downstream metabolite 3-phosphoglycerate (Fig. 6b) showed a
rapid return to baseline levels after the 15-min hydrogen peroxide
treatment, indicating a recovery of GAPDH activity (Fig. 6c).
Thus, oxidative inhibition of GAPDH allows transient partition-
ing of glucose carbon to the PPP for antioxidant purposes upon
oxidative stress, and resumption of glucose catabolism once ROS
levels fall.
In addition to the enrichment observed for metabolic proteins,
enrichment analysis of signiﬁcantly modiﬁed peptides showed a
strong enrichment for mitochondrial proteins (Fig. 4e). It has
been shown that protein cysteine content correlates with
organism complexity8. Considering the bacterial origin of
mitochondria, it is perhaps unsurprising that mitochondrial
proteins were found to have a lower cysteine content than other
cellular proteins in a bioinformatics comparison (8 vs. 12 cysteine
residues per protein, on average). Furthermore, the steady-state
redox potential of mitochondrial GSSG/GSH is more reduced as
compared to the cytosol38. Nevertheless, it has been shown that
mitochondrial proteins are highly sensitive to redox stress due to
the slightly higher pH in mitochondria, which favours the
reactivity of cysteine thiolates39. Additionally, mitochondria have
a high concentration of exposed protein thiols as compared to
their GSH concentration39. Among the signiﬁcantly modiﬁed
cysteine peptides after hydrogen peroxide were several compo-
nents of the mitochondrial electron transport chain (ETC), such
as Complex I (Ndufa5, Ndufaf7, Ndufs8, Ndufv1), Complex III
(Uqcrc2), and Complex IV (Cox6b1). To investigate the
consequences of this oxidation on mitochondrial function,
mitochondrial oxygen consumption rate (OCR) upon treatment
with hydrogen peroxide was monitored. Oxidation led to a rapid
and substantial decrease in OCR (Fig. 6d). Titrating different
concentrations of hydrogen peroxide showed that this was a dose-
dependent effect (Supplementary Fig. 2d). Together, these results
indicate that acute oxidative stress causes metabolic adaptation
through the oxidation of metabolic and mitochondrial proteins to
amplify the production of reducing equivalents in the PPP, and
potentially to minimise the production of endogenous ROS by
inhibition of mitochondrial respiration.
Chronic redox stress causes oxidation of metabolic proteins. To
test SICyLIA on a model of higher complexity, we used the
previously described immortalised primary kidney epithelial
Fh1ﬂ/ﬂ cells from mice with a homozygous conditionally targeted
Fh1 allele21. Fh1−/− cells were obtained by infecting Fh1ﬂ/ﬂ cells
with adenovirus expressing Cre recombinase22. These Fh1−/−
cells, previously shown to experience chronic oxidative stress24,
were compared to isogenic controls (Fh1ﬂ/ﬂ) using SICyLIA. Due
to cellular adaptation to the loss of Fh1 and concomitant changes
in protein expression, this model requires normalisation for
protein abundance as discussed above (Fig. 1b). Stable isotope
dimethyl labelling for relative protein quantiﬁcation of
Fh1−/− compared to Fh1ﬂ/ﬂ cells showed, unsurprisingly, that FH
is the most signiﬁcantly downregulated protein (Fig. 7a).
Additionally, glycolytic enzymes are overexpressed (Hk1, Gpi,
Pfkl, Tpi1, Pgk1, Pgam1, Eno1, Pkm, Ldha, Ldhb), as FH-deﬁcient
cells depend on glycolysis for ATP production due to truncation
of the tricarboxylic acid cycle. We have previously shown that
haem oxygenase (Hmox1) is synthetically lethal with FH22 and as
Fig. 7a indicates, HMOX1 is highly overexpressed in Fh1−/− cells.
Furthermore, in line with the recent elucidation of the mechan-
ism by which fumarate accumulation in these cells induces
epithelial-to-mesenchymal-transition (EMT)40, the protein
expression data showed a clear EMT signature exempliﬁed by
downregulation of E-cadherin (Cdh1) and epithelial cell adhesion
molecule (Epcam), as well as upregulation of vimentin (Vim)
(Fig. 7a).
Similar to the depth achieved for Fh1ﬂ/ﬂ cells treated with
hydrogen peroxide, 20,848 cysteine-containing peptides were
identiﬁed (Fig. 2a). After normalisation for protein abundance,
peptide oxidation ratios were obtained for 8681 peptides, which
belonged to 3006 protein groups. Of those, 252 (2.9%) cysteine-
containing peptides were considered signiﬁcantly modiﬁed in Fh1
−/− compared to Fh1ﬂ/ﬂ cells (Fig. 7b and Supplementary Data 2).
Comparable to the acute oxidative stress model, the standard
deviation for the majority of the peptides was low (Supplemen-
tary Fig. 3a). Functional annotations based on UniProt Feature
Keys showed that the majority of signiﬁcantly modiﬁed cysteine
residues were involved in disulphide bond formation (Supple-
mentary Fig. 3b). This was in contrast to hydrogen peroxide
treatment, where the majority were part of protein active sites
(Supplementary Fig. 3c). This may reﬂect the need for acute
adaptation upon hydrogen peroxide treatment through oxidation
of protein catalytic sites, such as observed for GAPDH (Figs. 5–6),
whereas a different adaptive response is required for chronic
oxidative stress conditions.
To further delineate cellular adaptation to redox stress, we
investigated whether the preferential oxidation of metabolic
proteins observed in acute oxidative stress conditions also holds
true for chronic oxidative stress. This was done by enrichment
analysis of the most comprehensive model of mammalian
metabolism, the Recon 2 metabolic network41. Peptides that
were considered signiﬁcantly modiﬁed based on their oxidation
ratio showed signiﬁcant enrichment for Recon 2, in both the
acute and chronic oxidative stress model (Fig. 7c). Enrichment
analysis of GO categories showed that the GOBP category of cell
redox homoeostasis was also signiﬁcantly enriched in both
models (Fig. 7c). We next investigated whether these enrichments
were driven by the same proteins. Surprisingly, the majority of
metabolic proteins signiﬁcantly modiﬁed were mutually exclusive
between the models (Fig. 7d). Of the eight proteins that were
shared, only four were modiﬁed on the same cysteine residue
(Aldh18a1, Cox6b1, P4hb, and Pla2g4a). Comparison of the
GOBP category cell redox homoeostasis showed greater overlap
between the two conditions (Fig. 7e), yet two redox proteins were
Fig. 4 Acute oxidative stress causes oxidation of predominantly metabolic and mitochondrial proteins. a Density scatterplot displaying log 2 median
peptide oxidation ratios vs. peptide intensity in Fh1ﬂ/ﬂ cells treated with 500 µM hydrogen peroxide for 15 min compared to untreated cells. Every square
represents a unique peptide; colour scale of the density of the data points in the corresponding region is indicated on the right. Highlighted green circles are
signiﬁcantly oxidised (positive values) or reduced (negative values) peptides. Gene names of corresponding peptides are displayed for the most
signiﬁcantly oxidised or reduced peptides. b Scatterplot displaying log 2 median peptide oxidation ratios vs. peptide intensity in Fh1ﬂ/ﬂ cells treated with
500 µM hydrogen peroxide for 15 min compared to untreated cells. Every symbol represents a unique peptide, with legend indicated. Coloured circles
represent peptides of which the cysteine residue has a Feature Key annotation in the UniProt database; squares represent those without this annotation.
Signiﬁcantly oxidised (positive values) or reduced (negative values) cysteine peptides within the annotated group are highlighted with their corresponding
gene name. Enriched c GO biological process (GOBP), d molecular function (GOMF), e and cellular compartment (GOCC) categories within signiﬁcantly
oxidised or reduced proteins compared to all proteins detected. a–e Based on four independent experiments, single measurement
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Fig. 5 Acute oxidative stress inhibits GAPDH activity to amplify NADPH production in the PPP. a Relative ratios of indicated intracellular glycolytic
metabolites after treatment with 500 µM hydrogen peroxide for 15 min. b Isotopologue distribution of intracellular metabolites in glycolysis and the
pentose phosphate pathway after incubation with 13C6-glucose and 500 µM hydrogen peroxide for 15 min. a, b All graphs show mean (S.D.) of three
independent experiments with triplicate measurements
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-04003-3
8 NATURE COMMUNICATIONS |  (2018) 9:1581 | DOI: 10.1038/s41467-018-04003-3 | www.nature.com/naturecommunications
only signiﬁcantly modiﬁed in chronic oxidative stress conditions,
despite being detected in both models (Gpx1 and Txnl1). These
results indicate that acute and chronic cellular oxidative stress
result in the oxidation of speciﬁc sets of proteins to help cells
adapt to these distinct physiological conditions. Additionally,
these results illustrate that the SICyLIA workﬂow is applicable to
mouse-derived cells with different basal proteomes, to inform on
proteins and pathways that are important in maintaining cellular
homoeostasis in response to chronic oxidative stress.
Chronic oxidative stress response in kidney tissues. Next, we
wanted to investigate whether our methodology and workﬂow
could be applied directly to study whole organs, using the pre-
viously described Fh1ﬂ/ﬂ Ksp1.3/Cre genetically engineered
mouse model (GEMM) of FH deﬁciency, which expresses Cre
recombinase under the kidney-speciﬁc cadherin promoter21. Loss
of Fh1 in the kidney results in the formation of severe renal cysts
in these mice21, as shown in Fig. 8a. Kidney tissue slices of Fh1ﬂ/ﬂ
Cre-negative control mice and Cre-positive mice in which Fh1
was lost (indicated hereafter as Fh1−/−) were subjected to the
same protein extraction and cysteine labelling strategies as cells,
and peptide oxidation ratios were normalised for protein abun-
dance. A total of 13,112 cysteine-containing peptides were iden-
tiﬁed (Fig. 2a). Of those, 4415 were robustly quantiﬁed peptides
according to our QC criteria, and these peptides belonged to 2168
protein groups. Comparable to the other models, the standard
deviation between replicates for the majority of peptides was low
(Supplementary Fig. 4a). Quantiﬁcation of protein cysteine oxi-
dation in the tissues identiﬁed a subset of 150 (3.4%) signiﬁcantly
modiﬁed peptides (Fig. 8b and Supplementary Data 3) and
functional annotations based on UniProt Feature Keys showed
that nearly all signiﬁcantly modiﬁed cysteine residues were
involved in disulphide bond formation (Supplementary Fig. 4b),
similar to the Fh1 cell model. Additionally, similarly to the Fh1
−/− cells, an enrichment in modiﬁed peptides of metabolic pro-
teins (as deﬁned by Recon 2) was also observed in the kidney
tissues. Signiﬁcantly modiﬁed peptides originated from various
components of the tissue architecture (Fig. 8b). These included
intracellular proteins, but also extracellular proteins present in the
vasculature and urine. Compared to the intracellular compart-
ment, the classical enzymatic antioxidant systems are scarce in
the blood. Serum albumin (Alb) is the main thiol and acts as the
major plasma antioxidant42. It was identiﬁed as the main target of
oxidation in patients with various types of kidney disease
(reviewed in42) and was oxidised on multiple peptides in the
mouse kidney tissues (Fig. 8b). This was also observed for the
serum protein hemopexin (Hpx), the scavenger protein of hae-
moglobin, which is produced by the liver to protect the body from
free haem-induced oxidative damage43. A component of the Von
Willebrord factor (Vwa5a), a blood glycoprotein involved in
haemostasis whose plasma levels increase in patients with urae-
mia44, was oxidised as well. Besides plasma proteins, certain
urinary proteins play a role in kidney disease and uromodulin
(Umod), the most abundant protein excreted in urine45 was
oxidised in the kidney. Other modiﬁed proteins were extracellular
matrix proteins and proteins involved in the degradation thereof
(such as Col6a1, Ctsb, Ctsd, Hspg2, Plg, and Vtn) and cytoskeletal
proteins (such as Flna, Syne2, Tbcc, and Lpp). Together, this may
indicate that chronic oxidative stress caused by the loss of Fh1
exerts its pathophysiological consequence of renal cyst formation
in these mice through oxidation of proteins involved in metabolic
processes and in maintaining tissue architecture, such as the
cytoskeletal and extracellular matrix proteins, despite ROS-
scavenging by intracellular, vascular, and urinary proteins.
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Comparison of signiﬁcantly modiﬁed proteins involved in cell
redox homoeostasis showed that although some proteins were
signiﬁcantly modiﬁed in more than one model, others were
modiﬁed in a mutually exclusive manner (Fig. 8c). Additionally,
several components of the mitochondrial ETC complexes were
signiﬁcantly modiﬁed (Fig. 8d), especially of Complex I. With the
exception of COX6B1, the components affected were distinct.
Taken together, these results further indicate that speciﬁc protein
modiﬁcations are necessary for cells to adapt to distinct oxidative
insults. However, four anti-oxidant proteins were modiﬁed in all
three models, which may suggest that oxidative modiﬁcation of
these proteins is universally required in conditions of redox stress.
Finally, these results indicate that similarly to the results obtained
in cell lines isolated from mice, our proteomics workﬂow is able
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to identify proteins modiﬁed by ROS in an animal organ that
contains a complex mixture of tissues and cell types. This is
especially exciting given the fact that the Ksp1.3/Cre transgenic
mice express Cre-recombinase solely in the epithelial cells of the
renal tubules46. Therefore, the kidney pathology observed is
caused by only a subset of cells that lose Fh1 and experience
accompanying increases in ROS21,24. Despite these more mild
alterations in vivo as compared to the cell lines that were
manipulated in vitro, the SICyLIA workﬂow achieved the
required sensitivity to identify protein cysteine residues modiﬁed
by chronic oxidative stress.
Discussion
In recent years, attention has shifted from ROS as agents of
oxidative damage to important regulators of cellular biology.
While several workﬂows have been described to study oxidative
modiﬁcation of proteins, the required depth of proteomic
investigation to achieve meaningful global peptide oxidation
patterns remains a technical challenge. Here, we have presented
SICyLIA: a comprehensive MS-based proteomic method to reli-
ably quantify protein oxidative modiﬁcation in cellular and ani-
mal models of oxidative stress. By quantifying free cysteine thiols,
which are the most abundant form of cysteine in the cell, and
using the loss of individual reduced thiols as readout of oxidation,
we capture all possible cysteine oxidative modiﬁcations. Despite
the elimination of enrichment steps, which requires extensive
sample manipulation and can introduce error and bias, the
SICyLIA workﬂow achieves a proteomic depth that enabled the
identiﬁcation of a large number of previously unknown redox-
sensitive peptides. SICyLIA allows investigation of the whole
proteome to obtain peptide oxidation and protein abundance
information from the same sample, even in a complex organ with
highly abundant vascular, urinary, and extracellular matrix pro-
teins. Importantly, this is achieved using a straightforward
workﬂow that is widely accessible to a broad audience of
researchers studying oxidative stress-mediated signalling and
diseases.
Recent ICAT-based studies identiﬁed ~500 ICAT-labelled
cysteine-containing peptides in oxidatively stressed S. pombe10
and 491 cysteine-containing peptides in D. melanogaster47. A
recent IodioTMT-based approach detected 1754 labelled cysteine-
containing peptides in a mammalian cell line treated with
hydrogen peroxide and DTT12. Furthermore, the OxiTMT
approach identiﬁed 1229 iodoTMT-labelled cysteine residues in
E. coli cultures treated with hydrogen peroxide13. A recent study
using the isoTOP-ABPP platform quantiﬁed cysteine reactivities
of more than 3000 cysteine residues in a human cell line (with
~9700 cysteine residues quantiﬁed across a panel of six lines)48.
During the preparation of this manuscript, another chemopro-
teomic approach titled quantitative thiol reactivity proﬁling
(QTRP) was published, which used iodoacetamide-alkyne probes,
click chemistry, and subsequent enrichment49. QTRP enabled
quantiﬁcation of cysteine reactivity to hydrogen peroxide of up to
~3700 peptides in a single human cell line and up to ~7000 across
a panel of four. Our SICyLIA approach shows considerable
improvement in cysteine-proteome coverage compared to all
these previous methodologies, quantifying cysteine oxidation
ratios for 4420 peptides in complex mouse kidney tissue samples
and over 9000 in a single cell line. This is particularly notable
considering the fact that SICyLIA does not require any click-
chemistry or enrichment for cysteine-containing peptides.
The results obtained with SICyLIA indicate that metabolic and
mitochondrial proteins are preferentially oxidised in acute oxi-
dative stress conditions (Fig. 4a, c, e) and cysteine residues that
reside on protein active sites were particularly reactive to
hydrogen peroxide (Fig. 4b). Oxidation of one such active site was
found on GAPDH and was part of the acute antioxidant response
to inhibit GAPDH activity in favour of redirecting glucose ﬂux
into the PPP to enhance NADPH production and detoxify ROS
(Figs. 5–6). Chronic oxidative stress due to Fh1 loss caused oxi-
dation of predominantly metabolic proteins as well (Fig. 7b, c).
However, the majority of the targeted proteins were distinct
(Fig. 7d) and the cysteine sites were not predominantly engaged
in protein active sites (Supplementary Fig. 3c). Additionally,
oxidation proﬁles of proteins dedicated to cell redox homo-
eostasis showed some exclusivity between these conditions
(Fig. 7e, 8c). These results emphasise that acute oxidative stress is
a distinct physiological state compared to chronic oxidative stress
caused by a genetic alteration, such as loss of FH, and requires
different adaptations. Taken together, our results indicate that
cysteine oxidation plays a key role in the metabolic adaptation to
redox stress and tailored metabolic and redox adaptations help
cells respond to acute and chronic oxidative stress.
Despite these differences, there were some striking similarities
between the three models investigated. Voltage-dependent anion
selective channels, the most abundant protein family in the
mitochondrial outer membrane, were found oxidised in all three
models (Vdac2, Vdac3). Oxidation of VDAC3 in particular has
been suggested to act as a sensor for mitochondrial damage, as
VDAC3 over-oxidation induced removal of damaged mitochon-
dria (recently reviewed in ref. 50). Additionally, components of
the mitochondrial ETC were modiﬁed in all models (Fig. 8d). A
recent report showed that Fh1-deﬁcient cells experience respira-
tory chain dysfunction, particularly at the level of Complex I51.
Considering the observed drop in OCR after hydrogen peroxide
treatment (Fig. 6d), ETC complex modiﬁcation by ROS is likely
to compromise mitochondrial respiration. As such, oxidation of
VDAC2 and VDAC3 may indicate increased turnover of
damaged mitochondria in response to ROS to maintain a func-
tional mitochondrial network. Future studies using SICyLIA in a
wide range of physiological models of oxidative stress will help
identify whether the protein oxidative modiﬁcations observed in
this study are speciﬁc to these models or present general cellular
adaptations to redox stress.
In summary, our results suggest that both acute and chronic
oxidative stress cause metabolic adaptation through direct oxidation
Fig. 7 Chronic oxidative stress due to Fh1 loss causes widespread protein oxidation. a Density scatterplot displaying log 2 median protein level ratios vs.
protein intensity in Fh1−/− cells compared to Fh1ﬂ/ﬂ cells. Every square represents a unique protein; colour scale of the density of the data points in the
corresponding region is indicated on the right. Positive values indicate more abundant and negative values less abundant proteins in Fh1−/− cells.
Highlighted green circles are selected proteins involved in adaptation to Fh1 loss with their corresponding gene names. b Density scatterplot displaying log
2 median peptide oxidation ratios vs. peptide intensity in Fh1−/− cells compared to Fh1ﬂ/ﬂ cells. Every square represents a unique peptide; colour scale of
the density of the data points in the corresponding region is indicated on the right. Highlighted green circles are signiﬁcantly oxidised (positive values) and
reduced (negative values) peptides. Gene names of corresponding proteins are displayed for the most signiﬁcantly oxidised or reduced peptides. c
Comparison of enrichment analyses for the indicated categories between the acute and chronic oxidative stress model. d Venn diagram showing overlap
and exclusivity of metabolic proteins, as deﬁned by Recon 2, that were found signiﬁcantly modiﬁed in the acute and chronic oxidative stress model. e Venn
diagram showing overlap and exclusivity of proteins involved in cell redox homoeostasis as deﬁned by GOBP that were found signiﬁcantly modiﬁed in the
acute and chronic oxidative stress model. a–e Based on four independent experiments, single measurement
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of metabolic and mitochondrial proteins. Furthermore, chronic
oxidative stress originating intracellularly can have profound effects
on organ tissue architecture and physiological homoeostasis
through oxidation of proteins excreted into circulating bioﬂuids.
We have demonstrated that superior sensitivity and proteomic
depth can be achieved using the SICyLIA workﬂow. Its application
to cells and tissues derived from a GEMM of FH deﬁciency indi-
cates that accurate peptide oxidation proﬁle can be obtained, even
when samples are complex and basal protein levels differ between
samples. This holds promise for future applications to the study of
tissues derived from patients and healthy donors in studies of
human diseases that are characterised by oxidative stress.
Methods
Sample preparation for proteomics. For cellular proteomics, Fh1ﬂ/ﬂ cells were
treated with 500 µM hydrogen peroxide 15 min prior to extraction for acute oxi-
dation experiments. For chronic oxidation experiments, Fh1ﬂ/ﬂ and Fh1−/− cells
were extracted without prior treatment. Plates were washed three times with
phosphate-buffered saline (PBS) and extraction solution was added at 80 µl per
well. Extraction solution consisted of 55 mM heavy (13C2D2H2INO) or light
(12C2H4INO) iodoacetamide in 100 mM Tris-HCl buffer (pH 8.5) with 4% SDS to
alkylate free cysteine thiols upon lysis. Cells were scraped immediately and lysates
were collected in Eppendorf tubes and sonicated (speed 2, amp 10) for 4 × 5 s. For
tissue proteomics, mice were sacriﬁced by cervical dislocation and kidney tissues
were harvested and snap frozen immediately using liquid nitrogen. Representative
samples were excised on dry ice, added to extraction solution, and homogenised
under dry ice vapour using a Precellys24 bead-based homogeniser (Bertin
Instruments) for 3 × 20 s at 5000 rpm. All samples were centrifuged at 16,000g for
5 min at 4 °C. Supernatant was transferred to new tubes and incubated in a table
top shaker in the dark at 1400 rpm for 1 h at room temperature. Protein
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Fig. 8 Analysis of mouse kidneys shows oxidation of proteins from various tissue compartments. a Representative image of Fh1ﬂ/ﬂ and Fh1−/− mouse
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concentration was determined by BCA assay and samples were stored at −80 °C
until further processing.
For each independent experiment, 150 µg of differentially labelled protein
extracts were mixed using a label-swap replication strategy (i.e. untreated-IAM-
heavy mixed with hydrogen peroxide-treated-IAM-light generates forward
replicate 1; untreated-IAM-light with hydrogen peroxide-treated-IAM-heavy
generates reverse replicate 1, etc.), ﬁnally obtaining four replicates for each
experimental model. Reversibly oxidised thiols were reduced with 70 mM DTT,
incubated at room temperature (24 °C) for 45 min and diluted 1:2 using 50 mM
ammonium bicarbonate solution (pH 7.0). Newly generated free thiols were
subsequently alkylated using 80 mM NEM. Proteins were then precipitated in two
steps using 24 and 10% solutions of trichloroacetic acid (TCA). In both steps,
pellets were incubated at 4 °C for 10 min and centrifuged at 18,000 g for 5 min.
Supernatants were carefully aspirated and pellets were ﬁnally washed with water
until the supernatant reached neutral pH. Pellets were reconstituted in 50 µl of 8 M
urea solution and submitted to a two-step digestion. First using Endoproteinase
Lys-C (ratio 1:33 enzyme:lysate, Alpha Laboratories) for 1 h at room temperature
(24 °C), after which partial digests were further diluted to 500 µl with 50 mM
ammonium bicarbonate (pH 7.0). This reduced the urea concentration below 1M
to allow for the second digestion with trypsin (ratio 1:33 enzyme:lysate, Promega)
overnight at room temperature (24 °C).
Dimethyl labelling. Dimethyl labelling was carried out on alkylated protein digests
using a label-swap replication strategy following the on-column protocol described
by Boersema et al.26.
Off-line HPLC fractionation. For SICyLIA proteomic experiments, both IAM and
dimethyl-modiﬁed protein digests were fractionated using reverse phase chroma-
tography. A C18 column (150 × 2.1 mm i.d. - Kinetex EVO (5 µm, 100 Å)) was
used with a Dionex HPLC system (Ultimate LPG-3000 binary pump and
UVD170U Ultraviolet detector). Modules were controlled by Chromeleon version
6.7. Solvent A (98% water, 2% Acetonitrile) and solvent B (90% Acetonitrile and
10% water) were adjusted to pH 10 using ammonium hydroxide. Samples were
injected manually through a Rheodyne valve onto the RP-HPLC column equili-
brated with 4% solvent B and kept at this percentage for 6 min. A two-step gradient
was applied at a ﬂow-rate of 200 µl/min (from 4–27% B in 36 min, then from
27–48% B in 8 min) followed by a 5 min washing step at 80% solvent B and a
10 min re-equilibration step, for a total run time of 65 min. Column eluate was
monitored at 220 and 280 nm, and collected using a Foxy Jr. FC144 fraction
collector (Dionex). Collection was allowed from 9 to 54 min for 90 s per vial (300
µl) for a total of 30 fractions. No fraction concatenation strategy was used; only the
ﬁrst 4 and the last 5 fractions were pooled resulting in 21 fractions in total.
UHPLC-MS/MS analysis. For SICyLIA proteomic experiments, fractionated
tryptic digests were separated by nanoscale C18 reverse-phase liquid chromato-
graphy using an EASY-nLC II 1200 (Thermo Scientiﬁc) coupled to a Q-Exactive
HF mass spectrometer (Thermo Scientiﬁc). Elution was carried out using a binary
gradient with buffer A (2% acetonitrile) and B (80% acetonitrile), both containing
0.1% formic acid. Samples were loaded with 8 µl of buffer A into a 20 cm fused
silica emitter (New Objective) packed in-house with ReproSil-Pur C18-AQ, 1.9 μm
resin (Dr Maisch GmbH). Packed emitter was kept at 35 °C by means of a column
oven (Sonation) integrated into the nanoelectrospray ion source (Thermo Scien-
tiﬁc). Peptides were eluted at a ﬂow rate of 300 nl/min using different gradients
optimised for three sets of fractions: 1–7, 8–15, and 16–21. Two-step gradients
were used, all with 20 min for step one and 7 min for step two. Percentages of
buffer B (%B) were changed as follows. For F1-7, %B was 2 at the start, 20 at step
one, and 39 at step two. For F8-14, %B was 4 at the start, 23 at step one, and 43 at
step two. For F15-21, %B was 6 at the start, 28 at step one, and 48 at step two.
All gradients were followed by a washing step (100% B) for 10 min followed by
a 5 min re-equilibration step (5%), for a total run time of 40 min. Eluting peptides
were electrosprayed into the mass spectrometer using a nanoelectrospray ion
source (Thermo Scientiﬁc). An Active Background Ion Reduction Device was used
to decrease air contaminants signal level.
For label-free quantitation analysis, proteins were digested as described above
and resulting tryptic peptides were desalted with a C-18 Stage-Tip52 and
subsequently injected using an EASY-nLC 1200 (Thermo Fisher Scientiﬁc) coupled
online to an Orbitrap Q-Exactive HF mass spectrometer. Peptides were eluted at
300 nl/min ﬂow into a 50 cm fused silica emitter (New Objective) packed in-house
with ReproSil-Pur C18-AQ, 1.9 μm resin (Dr Maisch GmbH). The gradient used
started at 2% of buffer B and was increased to 16% over 185 min, and then to 28%
over 30 min. Finally, a washing step at 95% of B was carried out over 10 min
followed by a 13 min re-equilibration at 5% B for a total duration of 243 min.
Ionisation conditions used include: spray voltage 2.1 kV, ion transfer tube
temperature 250 °C. Data were acquired using Xcalibur software (Thermo
Scientiﬁc) and acquisition was carried out in positive ion mode using data
dependent acquisition. A full scan (FT-MS) over mass range of 375–1400 m/z was
acquired at 60,000 resolution at 200 m/z, with a target value of 3,000,000 ions for a
maximum injection time of 20 ms. Higher energy collisional dissociation
fragmentation was performed on the 15 most intense ions, for a maximum
injection time of 50 ms, or a target value of 50,000 ions. Multiply charged ions
having intensity greater than 12,000 counts were selected through a 1.5 m/z
window and fragmented using normalised collision energy of 27. Former target
ions selected for MS/MS were dynamically excluded for 25 s.
Proteomics data analysis. The MS Raw data were processed with MaxQuant
software20 version 1.5.5.1 and searched with Andromeda search engine53, querying
UniProt28 Mus musculus (20/06/2016; 57,258 entries). First and main searches
were performed with precursor mass tolerances of 20 ppm and 4.5 ppm, respec-
tively, and MS/MS tolerance of 20 ppm. The minimum peptide length was set to six
amino acids and speciﬁcity for trypsin cleavage was required, allowing up to two
missed cleavage sites. Methionine oxidation and N-terminal acetylation were
speciﬁed as variable modiﬁcations, no ﬁxed modiﬁcations were speciﬁed. The
peptide, protein, and site false discovery rate (FDR) was set to 1 %. Modiﬁcation by
light and heavy iodoacetamide on cysteine residues (carbamidomethylation) was
set as label type modiﬁcation in Andromeda conﬁguration. Compositions set in the
software were: HNOCx(2)Hx(2) for heavy and H(3)NOC(2) for light label. As
such, cysteine-containing peptide pairs were treated in the same way as SILAC
pairs, and highly accurate median peptide ratios were obtained. These ratios were
then further normalised to the median of all ratios in each replicate. As the
MaxQuant algorithm searches for and identiﬁes only peptides that contain either
light or heavy carbamidomethylation on cysteine residues, peptides with NEM
labelling were not considered. Therefore, peptides with multiple cysteine residues
that carried both IAM and NEM modiﬁcations were excluded from the analysis. In
our data sets, 15–16% of peptides contain multiple cysteine residues and less than
3% (H2O2 model), 2% (Fh1 cell model), and 4% (Fh1 tissue model) carried mixed
labelling and were excluded.
For Fh1 cell and kidney tissue samples that required protein expression
normalisation, dimethylated samples were processed using: DimethLys0/Nter0 and
DimethLys8/Nter8 as light and heavy labels, respectively. Protein abundance was
then determined by MaxQuant, which calculates the median of the ratios between
light and heavy dimethyl modiﬁcations measured for all unique peptides from each
protein. Both data sets (iodoacetamide heavy/light and dimethyl heavy/light) were
processed at the same time in MaxQuant using different parameters, which were
deﬁned with the Parameter Groups option. Quantitation of cysteine oxidation
reported in the MaxQuant output peptide.txt ﬁle was used for the analysis. For LFQ
of proteins in hydrogen peroxide-treated and untreated samples, proteins were
quantiﬁed according to the LFQ algorithm in MaxQuant54.
MaxQuant output was further processed and analysed using Perseus software
version 1.5.5.327. Peptides with Cys count lower than one were excluded, together
with Reverse and Potential Contaminant ﬂagged peptides. Protein level
quantitation was done using the ProteinGroups.txt ﬁle. From the ProteinGroups.
txt ﬁle, Reverse and Potential Contaminant ﬂagged proteins were removed, and at
least one uniquely assigned peptide and a minimum ratio count of 2 were required
for a protein to be quantiﬁed. Only cysteine-containing peptides uniquely assigned
to one protein group within each replicate experiment were normalised and
included in the analysis. Only cysteine-containing peptides and protein groups that
were robustly quantiﬁed in three out of four replicate experiments (cells) or
replicate samples (tissues) were used for the analysis. QC was imposed by detecting
and excluding outliers by calculating upper fences (Q3+ 1.5IQR, where Q3 is the
third quartile and IQR is the interquartile range) of the distribution of CV% for all
median peptide oxidation ratios in each dataset and using these as cut-off. This led
to the exclusion of 578 (H2O2 model), 499 (Fh1 cell model), and 315 (Fh1 tissue
model) peptides. Throughout all further analyses, median peptide and protein
ratios were used to further minimise the effect of outliers.
Cell culture. Fh1ﬂ/ﬂ and Fh1−/− mouse primary kidney epithelial cells were iso-
lated, immortalised, and authenticated in our laboratory as described previously22.
Brieﬂy, kidney epithelial cells from mice with a homozygous conditionally targeted
Fh1 allele were immortalised (referred to as Fh1ﬂ/ﬂ cells; these express Fh1 protein
at a normal level). Next, Fh1−/− cells were obtained by infecting Fh1ﬂ/ﬂ cells with
adenovirus expressing Cre recombinase. Cells were maintained in DMEM (Invi-
trogen 21969-035, Thermo Fisher Scientiﬁc) supplemented with 2 mM glutamine
and 10% FBS. All experiments were carried out in medium containing physiolo-
gical concentrations of nutrients based on a formulation previously reported by our
lab55, containing 5.56 mM glucose, 0.65 mM glutamine, 0.1 mM sodium pyruvate,
and 2.5% FBS (referred to as experimental medium). Cells were plated in six-well
plates (Fh1ﬂ/ﬂ at 2.5 × 105 cells per well, Fh1−/− at 3.75 × 105 cells per well) using
2 ml medium per well and experiments were started after incubating for 20 h at 37 °
C and 5% CO2 for all experiments, except Seahorse analysis (speciﬁed below). Cell
lines were negative for mycoplasma as determined by MycoAlert™ Mycoplasma
Detection Kit (Lonza).
Mouse studies. For tissue proteomics, previously described male Fh1ﬂ/ﬂ Ksp1.3/
Cre mice were used that express Cre recombinase under the kidney-speciﬁc cad-
herin (Ksp-cadherin) promoter21. One Cre-positive mouse (referred to as Fh1−/−,
232 days old) was compared to a Cre-negative control mouse (referred to as Fh1ﬂ/ﬂ,
239 days old). Mice were sacriﬁced by cervical dislocation and kidneys were har-
vested and snap frozen immediately. Four representative kidney tissue slices were
used per mice, two from each kidney. No statistical method was used to
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predetermine sample size. The experiments were not randomised. The investigators
were not blinded to allocation during experiments and outcome assessment.
Animal work was carried out with ethical approval from the University of Glasgow
under the Animal (Scientiﬁc Procedures) Act 1986 and the EU Directive 2010 (PPL
70/8645).
Hydrogen peroxide quantiﬁcation. Phenylboronate (C6H7BO2, Sigma 78181) was
used as a probe to detect and quantify hydrogen peroxide, developed based on the
methodology described in56. In alkaline conditions, the nucleophilic peroxide
attacks the boronic acid and forms a negatively charged tetrahedral boronate
intermediate. The weak C–B bond undergoes a 1,2-insertion, which makes the C-
bond migrate to the peroxide oxygen atoms. The newly formed borate ester is
quickly hydrolysed by water to phenol. Brieﬂy, reaction solution was prepared by
diluting phenylboronate (stock solution 60 mM in EtOH) to 1 mM using TBS-T
(pH 11 for experimental samples and positive control, pH 7.5 for negative control).
To detect hydrogen peroxide in media, 30 µl of medium was added to 200 µl of
reaction solution. As a positive control, 30 µl of 500 µM hydrogen peroxide in water
was added to 200 µl of reaction solution. Additionally a standard curve was gen-
erated for quantiﬁcation purposes using various concentrations of hydrogen per-
oxide. As a negative control, 30 µl of 500 µM hydrogen peroxide was added to 20 µl
of 0.2 mg/ml catalase (Sigma) in PBS and incubated for 10 min at room tem-
perature, before adding to reaction solution. All samples were vortexed for 2 s and
incubated at 80 °C for 7 min, before 400 µl of LC-MS extraction solution (5:3:2
methanol:acetonitrile:H2O) was added. Samples were incubated in a shaker at max
speed for 10 min at room temperature before centrifuging at 16,000 g for 10 min.
Supernatants were transferred to glass vials and stored at −80 °C until LC-MS
analysis. Phenol (C6H6O) generated by the reaction between phenylboronate and
hydrogen peroxide was detected using LC-MS as described below.
Cell proliferation assay. Hydrogen peroxide was spiked into the medium at
indicated concentrations. After 15 min, residual hydrogen peroxide was removed
by aspirating and replenishing the medium. Cell proliferation was monitored by
counting live cells at indicated time points.
Colony formation assay. Hydrogen peroxide was spiked into the medium at
indicated concentrations. After 15 min, residual hydrogen peroxide was removed
by aspirating the medium and cells were trypsinised. Cells were diluted 1:40 in PBS
and 200 µl of cell solution was plated in six-well plates with 2 ml of medium per
well. Medium was replaced every 3 days and experiments were stopped after 8 days
by ﬁxing colonies with 10% TCA overnight at 4 °C. Next day, colonies were stained
by addition of 0.04% SRB in 1% acetic acid for 30 min. After four wash cycles with
1% acetic acid, plates were air dried and scanned using an Odyssey scanner (LI-
COR, Inc.). Images were exported using Image Studio software (Lite Ver 5.2, LI-
COR, Inc.) in grayscale (signal range 60–1800, K:1) and quantiﬁed using an ImageJ
plugin designed in-house.
Isotope tracing experiments. Uniformly labelled glucose (13C6-glucose) was used
at equimolar amounts as found in experimental medium (5.56 mM) and both 13C6-
glucose and 500 µM hydrogen peroxide were spiked into the medium at time point
0 and metabolites were extracted after 15 min (Fig. 3d and Fig. 5a, b). For recovery
experiments (Fig. 6a–c), residual hydrogen peroxide was removed after 15 min by
aspirating and replenishing the medium and metabolites were extracted at indi-
cated time points.
Extraction of metabolites and HPLC-MS analysis. Metabolites were extracted
and analysed as described previously57. Brieﬂy, cells were washed twice with ice-
cold PBS before LC-MS extraction solution (5:3:2 methanol:acetonitrile:H2O) was
added at 1 ml per well of a six-well plate. Plates were incubated for 5 min at 4 °C.
Next, extraction solution was transferred to microcentrifuge tubes and centrifuged
at 16,000g for 10 min at 4 °C. Supernatants were transferred to glass HPLC vials
and stored at −80 °C until analysis LC-MS analysis. For HPLC-MS analysis a ZIC-
pHILIC column (SeQuant, VWR) was used and Exactive and Q-Exactive mass
spectrometers (Thermo Fisher Scientiﬁc) were operated with electrospray (ESI)
ionisation and polarity switching mode at scan range (m/z) 75–1000 at a resolution
of 25,000 at 200 m/z. Data were acquired using Xcalibur software (Thermo Fisher
Scientiﬁc) and peak areas of metabolites were determined using TraceFinder
software (Thermo Fisher Scientiﬁc) by identifying metabolites using mass and
known retention time following in-house analysis of commercial standards on our
systems. Metabolites were normalised to cellular protein content by Lowry assay
performed on extracted cell monolayers.
OCR measurements. Fh1ﬂ/ﬂ cells were plated at 3 × 104 cells per well using 200 µl
medium per well onto Seahorse XFe96 plates (Agilent) and incubated overnight at
37 °C and 5% CO2. Then, the medium was replaced with 150 µl unbuffered Sea-
horse XF Base Medium (Agilent) supplemented with 5.56 mM glucose, 0.65 mM
glutamine, 0.1 mM sodium pyruvate (equal to experimental medium used in other
experiments) and 1% FBS (pH 7.4) and cells were placed in a CO2-free incubator at
37 °C for 30 min. OCR was recorded using a Seahorse XFe96 Extracellular Flux
Analyzer (Agilent) at baseline and after injection of medium (untreated condition)
or indicated concentrations of hydrogen peroxide. OCR was normalised to basal
OCR of untreated cells.
Histology. Mouse kidney tissues were ﬁxed in 10% buffered formalin and parafﬁn
embedded. Sections (4 µm) were stained with H&E and digital images were
acquired using a Leica SCN400f slide scanner.
Bioinformatics. Feature Key annotations for cysteine residues were downloaded
from UniProt (Mus musculus proteome downloaded on 03/11/2017;
51,950 sequences)28. Annotations from subcategories Function (Active site, Bind-
ing site, Metal binding and Site) and PTM/Processing (Disulphide bond, Modiﬁed
residues and Post-translational modiﬁcations) were included and linked to Leading
razor protein and Cysteine position of all identiﬁed cysteine-containing peptides
using Perseus software version 1.5.5.3. The 1789 enzyme-encoding genes included
in Recon 241 were converted to mouse associated genes using Ensembl BioMart
tool (Ensembl version 85, ref. 58), resulting in a list of 1740 mouse metabolic genes
that was used for enrichment analysis. Enrichment analyses of Recon 2 and GO
categories30,31 were performed using Perseus. To further analyse the individual
proteins contained in enriched GO categories, they were queried using the AmiGO
web application59. The GOBP category of cell redox homoeostasis (GO:0045454)
for Mus musculus was downloaded on 07/10/2017. Global protein cysteine content
analysis of the metabolic and mitochondrial proteome was done based on anno-
tation of GOBP category of metabolic process (GO:0008152) and GOCC category
of mitochondrion (GO:0005739), respectively, which were downloaded for Mus
musculus on 22/02/2017.
Statistical methods. The numbers of independent experiments and replicates are
indicated in ﬁgure legends. Error bars represent standard deviations. For hydrogen
peroxide quantiﬁcation experiments, linear regression analyses were performed
using GraphPad Prism 7.02 software (GraphPad Software Inc, San Diego, USA).
For LFQ proteomics experiments, to determine whether protein abundance dif-
fered signiﬁcantly between samples in hydrogen peroxide experiments, a two-sided
t-test was applied using the recommended settings in Perseus software version
1.5.5.3. The eight individual LFQ measurements for untreated and hydrogen
peroxide-treated samples were grouped according to treatment, no grouping was
preserved in randomisations, and the number of randomisations was 250 (FDR
0.05, S0= 0.1). To deﬁne signiﬁcantly oxidised or reduced cysteine peptides for all
SICyLIA proteomic experiments, the two-sided Signiﬁcance B algorithm20 was
applied to the median oxidation ratio of the replicate samples for each unique
peptide using Perseus. This algorithm calculates the probability that a log-ratio of
at least the magnitude observed is obtained (with the Benjamini-Hochberg cor-
rection for multiple hypothesis testing). By creating intensity bins of equal occu-
pancy, the effect of peptide intensity on their statistical spread is taken into
account60. Cysteine peptides were considered signiﬁcantly oxidised or reduced if
they passed the threshold value of 0.05 (Benjamini–Hochberg FDR used for
truncation). For a more detailed description of this algorithm and a substantiation
of the statistical approach used, see Supplementary Note 1. Kernel density plots of
the p-values were constructed in R version 3.4.3 using RStudio version 1.1.423 (bw
= 0.4). In order to deﬁne signiﬁcantly enriched GO categories within the sig-
niﬁcantly modiﬁed peptides, the Fisher exact test was applied using Perseus.
Categories were considered signiﬁcantly enriched if they passed the threshold value
of 0.05 (Benjamini-Hochberg FDR used for truncation, with relative enrichment on
leading razor protein). For Seahorse experiments, repeated measures two-way
ANOVA with Dunnet’s test for multiple comparisons correction was performed
using GraphPad Prism 7.02 software. Signiﬁcance threshold for the multiplicity
adjusted p value was 0.05 (95% conﬁdence interval). No statistical method was used
to predetermine sample size for the experiments.
Reagents. 13C6-glucose (CLM-1396-5) was obtained from Cambridge Isotopes
Laboratories (Tewksbury, MA, USA). Labelled (13C2D2H2INO, 721328) and
unlabelled (C2H4INO, I6125) iodoacetamide and all other remaining reagents were
obtained from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). For labelled
iodoacetamide, the purity (GC), 13C enrichment, and D enrichment were all 99%
as determined by Sigma-Aldrich.
Data availability. The raw MS ﬁles and search/identiﬁcation ﬁles obtained with
MaxQuant have been deposited to the ProteomeXchange Consortium via the
PRIDE partner repository61 with the dataset identiﬁers PXD006363 for the H2O2
model, PXD006372 for the Fh1 cell model, and PXD006373 for the Fh1 tissue
model. All other data from this study are available from the authors upon rea-
sonable request.
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